Zosano Pharma Corporation (ZSAN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zosano Pharma Corporation

    NASDAQ: ZSAN · Real-Time Price · USD
    0.56
    0.00 (0.43%)
    At close: Apr 24, 2025, 3:47 PM

    Zosano Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 785K
    Cost of Revenue
    		 796K
    Gross Profit
    		 -11K
    Operating Income
    		 -29.74M
    Interest Income
    		 3K
    Pretax Income
    		 -29.93M
    Net Income
    		 -30.11M
    Selling & General & Admin
    		 10.55M
    Research & Development
    		 20.97M
    Other Expenses
    		 n/a
    Operating Expenses
    		 31.52M
    Interest Expense
    		 189K
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 32.32M
    Income Tax Expense
    		 189K
    Shares Outstanding (Basic)
    		 112.06M
    Shares Outstanding (Diluted)
    		 112.06M
    EPS (Basic)
    		 -0.27
    EPS (Diluted)
    		 -0.27
    EBITDA
    		 -27.98M
    EBIT
    		 -29.74M
    Depreciation & Amortization
    		 1.75M

    Add to Watchlist